对非类固醇抗炎药物的代谢反应
Soumita Ghosh1, Nick Lahens1, Kayla Barekat1
1Institute for Translational Medicine and Therapeutics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, United States.
bioRxiv : the preprint server for biology
|December 16, 2024
概括
纳普罗是一种常见的止痛药,通过取代它来降低必需的托芬水平,而不是通过抑制Cox酶来降低. 在小鼠中服用托芬补充剂可以抵消纳普罗的作用.
科学领域:
- 药理学 药理学是指药理学的学科.
- 生物化学 生化学
- 免疫学 免疫学 免疫学
背景情况:
- 非类固醇抗炎药物 (NSAIDs) 缓解疼痛和炎症,但对胃肠道和心血管系统构成风险.
- 传统的NSAID和选择性循环氧化酶-2 (COX-2) 抑制剂,如赛莱科西布,具有不同的安全性.
- 托芬代谢对免疫功能至关重要,对情绪障碍有影响.
研究的目的:
- 为了比较纳普罗和塞莱科西布对人类和小鼠的托代谢的影响.
- 阐明纳普洛影响托水平的机制.
- 调查托补充剂是否可以减轻纳普罗诱导的副作用.
主要方法:
- 人类志愿者接受了纳普洛克森或塞莱科克西布,并测量了托和金林的血水平.
- 研究在小鼠中复制,以验证人类的发现.
- 进行了实验,以区分COX抑制和直接取代作为减少托的机制.
- 用纳普洛森治疗的小鼠接受了托补充剂,以评估其保护作用.
主要成果:
- 在人类和小鼠中,纳普洛克森治疗导致了血三甲和金林水平的降低.
- 低酸盐的减少归因于纳普罗森取代结合酸盐,独立于COX-1或COX-2抑制.
- 在接受纳普洛森治疗的小鼠中,补充三改善了便血液损失,并减少了IL-1β驱动的炎症基因表达在心脏中.
结论:
- 纳普洛克森对托芬水平的影响主要是由于位移,而不是COX抑制.
- 托芬在缓解纳普洛克森诱导的胃肠道和心脏炎症方面发挥着作用.
- 这些发现表明NSAID相关副作用的新机制以及涉及托芬的潜在治疗策略.
相关概念视频
Drug Metabolism: Phase II Reactions
3.6K
Phase II reactions are essential for the detoxification and elimination of drugs from the body. These reactions involve the conjugation of parent drugs or their phase I metabolites with endogenous molecules, resulting in more hydrophilic drug conjugates. The primary conjugation reactions in this phase are sulfation and glucuronidation. Both sulfation and glucuronidation typically produce biologically inactive metabolites. However, in some cases involving prodrugs, active metabolites may be...
3.6K
Drug Metabolism: Phase I Reactions
3.1K
A phase I reaction is a biochemical process that introduces a functionally reactive polar group to a substance. This transformation predominantly occurs in the liver, facilitated by the cytochrome P450 system of hemoproteins situated in the lipophilic endoplasmic reticulum of cells. The metabolite generated through this process can have varying polarities. If it is sufficiently polar, it can be easily excreted in the urine due to its water compatibility. However, if the metabolite is nonpolar,...
3.1K
Drugs for Treatment of Crohn's Disease in IBD Using Immunomodulatory Agents
141
Crohn's disease is an inflammatory bowel disorder marked by chronic inflammation of the GI tract. Various treatment strategies for Crohn's disease are employed, such as immunomodulatory agents, glucocorticoids, and biologics or anti-TNF therapy. Azathioprine (Imuran), a commonly used immunomodulatory drug for Crohn's disease, is converted in the body to mercaptopurine, which inhibits purine biosynthesis and cell proliferation. Both are utilized in severe cases of Inflammatory Bowel...
141
Drugs for Treatment of Ulcerative Colitis in IBD
119
Ulcerative colitis is a chronic inflammatory condition primarily affecting the colon and rectum. The primary drugs used in the treatment of ulcerative colitis are aminosalicylates. They exhibit anti-inflammatory and immunosuppressive properties. They modulate inflammatory mediators and inhibit the activity of nuclear factor κB (NF-κB). Aminosalicylates also reduce inflammation by inhibiting prostaglandin and leukotriene production and decreasing neutrophil chemotaxis and superoxide...
119
Inflammatory Response
1.8K
An inflammatory response is a localized, nonspecific immune reaction that occurs when a tissue is injured. It is characterized by redness, swelling, heat, and pain, which are commonly called the cardinal signs and symptoms of inflammation. Inflammation can sometimes result in a loss of function.
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
Inflammation can be triggered by various stimuli, such as impact, abrasion, chemical irritation, infections, and extreme hot or cold temperatures. These can damage cells and connective tissue fibers,...
1.8K
Drugs for Treatment of Crohn's Disease in IBD Using Glucocorticoids
95
Glucocorticoids, a class of anti-inflammatory drugs, are pivotal in treating moderate to severe Crohn's disease by inducing remission. They exhibit their anti-inflammatory action by inhibiting the production of inflammatory cytokines such as tumor necrosis factor (TNF)-α, interleukin (IL)-1, and chemokines like IL-8. In addition, they reduce the expression of inflammatory cell adhesion molecules and inhibit gene transcription of nitric oxide synthase, phospholipase A2, cyclooxygenase-2...
95


